KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulgent Genetics (FLGT) Change in Acquisitions & Divestments (2017 - 2025)

Historic Change in Acquisitions & Divestments for Fulgent Genetics (FLGT) over the last 9 years, with Q3 2025 value amounting to $40.2 million.

  • Fulgent Genetics' Change in Acquisitions & Divestments fell 6588.37% to $40.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $204.7 million, marking a year-over-year decrease of 5003.44%. This contributed to the annual value of $349.8 million for FY2024, which is 3121.83% down from last year.
  • Per Fulgent Genetics' latest filing, its Change in Acquisitions & Divestments stood at $40.2 million for Q3 2025, which was down 6588.37% from $60.2 million recorded in Q2 2025.
  • In the past 5 years, Fulgent Genetics' Change in Acquisitions & Divestments registered a high of $141.4 million during Q1 2023, and its lowest value of $14.5 million during Q1 2021.
  • Over the past 5 years, Fulgent Genetics' median Change in Acquisitions & Divestments value was $61.3 million (recorded in 2022), while the average stood at $68.8 million.
  • In the last 5 years, Fulgent Genetics' Change in Acquisitions & Divestments surged by 73631.82% in 2021 and then tumbled by 6600.84% in 2025.
  • Over the past 5 years, Fulgent Genetics' Change in Acquisitions & Divestments (Quarter) stood at $22.3 million in 2021, then skyrocketed by 351.59% to $100.8 million in 2022, then surged by 30.6% to $131.7 million in 2023, then plummeted by 45.48% to $71.8 million in 2024, then tumbled by 43.95% to $40.2 million in 2025.
  • Its last three reported values are $40.2 million in Q3 2025, $60.2 million for Q2 2025, and $32.4 million during Q1 2025.